Anzeige
Mehr »
Samstag, 07.02.2026 - Börsentäglich über 12.000 News
Der Shakeout: Silber hat genau das getan, was echte Bullenmärkte immer tun - es hat die Touristen abgeschüttelt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A14156 | ISIN: GB00BYMT0J19 | Ticker-Symbol: LIA
Stuttgart
06.02.26 | 21:56
56,00 Euro
0,00 % 0,00
1-Jahres-Chart
LIVANOVA PLC Chart 1 Jahr
5-Tage-Chart
LIVANOVA PLC 5-Tage-Chart
RealtimeGeldBriefZeit
56,0056,5011:22
56,0056,5006.02.

Aktuelle News zur LIVANOVA Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
30.01.Medizintechnik: KeyBanc favorisiert LivaNova, ICU Medical und Steris4
20.01.LivaNova to Announce Fourth-Quarter and Full-Year 2025 Results5
20.01.LivaNova PLC: LivaNova to Announce Fourth-Quarter and Full-Year 2025 Results223LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, will host a conference call to discuss its fourth-quarter and full-year 2025 results on Wed., Feb. 25, 2026, at 1 p.m. London...
► Artikel lesen
14.01.LivaNova PLC - 8-K, Current Report-
LIVANOVA Aktie jetzt für 0€ handeln
07.01.6 Analysts Assess LivaNova: What You Need To Know2
07.01.Livanova: Stifel hebt Kursziel auf 70 US-Dollar - Herz-Lungen-Sparte als Wachstumsmotor3
07.01.Stifel raises Livanova stock price target to $70 on cardiopulmonary growth2
29.12.25LivaNova CEO talks growth roadmap as company targets sleep apnea, depression therapies1
23.12.25LivaNova to Present at J.P. Morgan Healthcare Conference in January1
23.12.25LivaNova PLC: LivaNova to Present at J.P. Morgan Healthcare Conference in January261LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced it will present at the J.P. Morgan 44th Annual Healthcare Conference in San Francisco. Vladimir Makatsaria...
► Artikel lesen
19.12.25KeyBanc initiates Livanova stock with Overweight rating, cites growth outlook1
19.12.25KeyBanc startet Livanova-Coverage mit "Overweight" und verweist auf Wachstumsaussichten1
03.12.25LivaNova to Highlight Real-World Evidence from CORE-VNS Study and New Health Economics Analyses at American Epilepsy Society 2025 Annual Meeting2
03.12.25LivaNova PLC: LivaNova to Highlight Real-World Evidence from CORE-VNS Study and New Health Economics Analyses at American Epilepsy Society 2025 Annual Meeting359Eight scientific posters demonstrate significant seizure reduction and improved outcomes with VNS Therapy in patients with Drug-Resistant Epilepsy LivaNova PLC (Nasdaq: LIVN), a market-leading...
► Artikel lesen
02.12.25LivaNova Appoints Lucile Blaise as Global Head of Commercialization, Obstructive Sleep Apnea1
02.12.25LivaNova PLC: LivaNova Appoints Lucile Blaise as Global Head of Commercialization, Obstructive Sleep Apnea480LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, announced Lucile Blaise has joined the Company as Global Head of Commercialization, Obstructive Sleep Apnea (OSA), effective...
► Artikel lesen
25.11.25LivaNova to Present at Piper Sandler Healthcare Conference in December1
25.11.25LivaNova PLC: LivaNova to Present at Piper Sandler Healthcare Conference in December258LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced that Alex Shvartsburg, Chief Financial Officer, will present a general business update during a fireside chat...
► Artikel lesen
24.11.25LivaNova's VNS Therapy for Drug-Resistant Epilepsy Procedures Receives Increased Provider Reimbursement from U.S. Centers for Medicare & Medicaid Services3
24.11.25Höhere Medicare-Vergütung für LivaNova-Epilepsiebehandlung ab 20263
Weiter >>
59 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1